Which nasal decongestants are safe for use in a pregnant woman?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 11, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Safe Nasal Decongestants in Pregnancy

Avoid all oral decongestants (pseudoephedrine, phenylephrine) during the first trimester, and use intranasal corticosteroids instead—they are the safest and most effective option throughout pregnancy. 1

First-Line Therapy: Intranasal Corticosteroids

Intranasal corticosteroids are the preferred decongestant therapy during pregnancy because they have negligible systemic absorption and extensive safety data showing no increased risk of major malformations, preterm delivery, low birth weight, or pregnancy-induced hypertension. 2

Specific Agent Selection:

  • Budesonide (Rhinocort) is the preferred first-line choice when initiating therapy during pregnancy due to FDA Pregnancy Category B classification and the most extensive human safety data. 2

  • Fluticasone propionate (Flonase) should be continued without interruption if already using it before pregnancy, as discontinuing effective therapy unnecessarily worsens quality of life and potentially comorbid conditions like asthma. 2

  • Mometasone (Nasonex) is explicitly listed as safe by expert panels at recommended doses. 2

  • Use the lowest effective dose that adequately controls symptoms throughout all trimesters. 2

Why Oral Decongestants Must Be Avoided

Oral decongestants (pseudoephedrine, phenylephrine) are associated with congenital malformations including gastroschisis and small intestinal atresia, particularly when used during the first trimester. 1

  • The risk is further increased when oral decongestants are combined with acetaminophen or salicylates. 1

  • Oral decongestants also contribute to maternal hypertension, which is particularly problematic in pregnancy. 1

  • Expert consensus from multiple guidelines uniformly recommends against oral decongestant use during pregnancy. 1

Topical Nasal Decongestants: Use With Extreme Caution

Topical nasal decongestants (oxymetazoline, phenylephrine sprays) have not been adequately studied for safety in pregnancy and should be avoided or used only for very short durations (maximum 3-5 days). 1

Critical Pitfalls:

  • Despite topical administration, these agents undergo systemic absorption and can cause fetal heart rate changes, confirming they cross into systemic circulation and affect the fetus. 3

  • Cerebrovascular adverse events including stroke and ischemic optic neuropathy have been reported with intranasal decongestants, demonstrating significant systemic bioavailability. 3

  • Overuse leads to rhinitis medicamentosa (rebound congestion), which is particularly problematic in pregnancy rhinitis where women tend to overuse these medications for temporary relief. 4, 5, 6

Safe Non-Pharmacologic Alternatives

These options are safe throughout all trimesters and should be first-line for mild symptoms:

  • Saline nasal rinses/lavage are safe and effective for symptom relief. 1, 3

  • Nasal valve dilators (mechanical alar dilators) provide safe relief from nasal congestion. 7, 5, 6

  • Exercise and positioning can help reduce nasal congestion. 7

  • Adequate hydration and warm facial packs provide additional comfort. 3

Treatment Algorithm by Trimester

First Trimester (Weeks 1-13):

  • Absolutely avoid oral decongestants (pseudoephedrine, phenylephrine). 1
  • Start with saline rinses and nasal valve dilators. 3, 7
  • If pharmacologic therapy needed: budesonide intranasal spray is preferred. 2
  • Avoid topical nasal decongestants unless absolutely necessary, and limit to ≤3 days. 4, 5

Second and Third Trimesters (Weeks 14-40):

  • Intranasal corticosteroids remain first-line (budesonide, fluticasone, mometasone). 2, 7
  • Oral decongestants should still be avoided due to hypertension risk and lack of efficacy in chronic conditions. 1
  • Topical nasal decongestants may be used for very short courses (≤3-5 days) if intranasal corticosteroids are insufficient, but this is not ideal. 8

Special Considerations for Pregnancy Rhinitis

Pregnancy rhinitis affects one in five pregnant women and is defined as nasal congestion in the last 6+ weeks of pregnancy without infection or allergic cause, resolving within 2 weeks postpartum. 4, 5

  • Intranasal corticosteroids have not been shown to be effective specifically for pregnancy rhinitis (as opposed to allergic rhinitis), though they remain safer than alternatives. 4, 5

  • Education that symptoms will resolve after delivery can offer relief. 7

  • Smoking cessation and house dust mite avoidance are important, as these are probable risk factors. 4, 5

When Antibiotics Are Needed (Bacterial Sinusitis)

If true bacterial sinusitis develops (symptoms ≥10 days without improvement, or worsening after initial improvement):

  • Azithromycin is first-line due to safety profile and effectiveness. 3

  • Amoxicillin (high-dose: 90 mg/kg/day, maximum 1g every 12 hours) or amoxicillin-clavulanate are alternatives. 3

  • Continue intranasal corticosteroids alongside antibiotics for inflammation control. 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Use of Flonase During Pregnancy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Treatment of Sinusitis in First Trimester Pregnancy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

The etiology and management of pregnancy rhinitis.

American journal of respiratory medicine : drugs, devices, and other interventions, 2003

Research

Clinical and pathogenetic characteristics of pregnancy rhinitis.

Clinical reviews in allergy & immunology, 2004

Research

Special considerations in the treatment of pregnancy rhinitis.

Women's health (London, England), 2005

Research

Medical management of rhinitis in pregnancy.

Auris, nasus, larynx, 2022

Research

Treating common problems of the nose and throat in pregnancy: what is safe?

European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2008

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.